Therapeutic Drug Monitoring

<p>Chapter 1. Introduction to Therapeutic Drug Monitoring: Frequently and Less Frequently Monitored Drugs </p> <p>Chapter 2. Effects of Pre-Analytical Variables in Therapeutic Drug Monitoring </p> <p>Chapter 3. Analytical Techniques used in Therapeutic Drug Monitoring </p> <p>Chapter 4. Clinical Utility of Free Drug Monitoring </p> <p>Chapter 5. Current Practice of Therapeutic Drug Monitoring: Dose Adjustment of Drugs using Pharmacokinetic models</p> <p>Chapter 6. An Introduction to Personalized Medicine </p> <p>Chapter 7. Application of Ultra-High Throughput Sequencing and Microarray Technologies in Pharmacogenomics Testing</p> <p>Chapter 8. Pharmacogenomics and Warfarin therapy</p> <p>Chapter 9. Applications of Pharmacokinetic and Pharmacodynamic Principles to Optimize Drug Dosage Selection: Example of Antibiotic Therapy Management</p> <p>Chapter 10. Guidelines for Monitoring of Vancomycin, Aminoglycosides and certain antibiotics .</p> <p>Chapter 11. Challenges in Therapeutic Drug Monitoring of Digoxin and other Antiarrhythmic Drugs </p> <p>Chapter 12. Therapeutic Drug Monitoring of Classical and Newer Anticonvulsants </p> <p>Chapter 13. Challenges in Therapeutic Drug Monitoring of Classical Tricyclic and Newer Antidepressants: Analytical and Pharmacogenetics Considerations</p> <p>Chapter14. Therapeutic Drug Monitoring of Selected Anticancer Drugs: Pharmacogenomics issues </p> <p>Chapter 15. Immunosuppressive Drug Monitoring: Limitations of Immunoassays and the Application of Liquid Chromatography Mass Spectrometry</p> <p>Chapter 16. Biomarkers: The Link between Therapeutic Drug Monitoring and Pharmacodynamics of Immunosuppressants</p> <p>Chapter 17. Therapeutic Drug Monitoring of Antiretroviral Drugs in the Management of Human Immunodeficiency Infection </p> <p>Chapter 18. Drug Testing in Pain Management</p> <p>Chapter 19. Role of Therapeutic Drug Monitoring to Identify Clinically Significant Drug-Herbal Supplement Interaction </p>